Alphatec is a medical devices business based in the US. Alphatec shares (ATEC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.93 – an increase of 13.75% over the previous week. Alphatec employs 839 staff and has a trailing 12-month revenue of around $572.7 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $9.93 |
|---|---|
| 52-week range | $4.88 - $17.34 |
| 50-day moving average | $6.26 |
| 200-day moving average | $10.12 |
| Wall St. target price | $16.75 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.26 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $9.57 from 2024-11-19
| 1 week (2024-11-14) | 9.62% |
|---|---|
| 1 month (2024-10-21) | 78.54% |
| 3 months (2024-08-21) | 68.49% |
| 6 months (2024-05-21) | -10.39% |
| 1 year (2023-11-21) | -16.49% |
|---|---|
| 2 years (2022-11-21) | 0.74% |
| 3 years (2021-11-19) | 11.27 |
| 5 years (2019-11-21) | 33.47% |
| Revenue TTM | $572.7 million |
|---|---|
| Gross profit TTM | $233.1 million |
| Return on assets TTM | -12.1% |
| Return on equity TTM | -21137.14% |
| Profit margin | -31.06% |
| Book value | $-0.01 |
| Market Capitalization | $1.2 billion |
TTM: trailing 12 months
We're not expecting Alphatec to pay a dividend over the next 12 months.
Alphatec's shares were split on a 1:12 basis on 24 August 2016 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Alphatec shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Alphatec shares which in turn could have impacted Alphatec's share price.
Over the last 12 months, Alphatec's shares have ranged in value from as little as $4.88 up to $17.339. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alphatec's is 1.314. This would suggest that Alphatec's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Alphatec Holdings, Inc. , a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.